AbbVie · 19 hours ago
2026 Product Development, Science, and Technology Intern
North Chicago, IL
Internship
Onsite
Intern
$20/hr - $36/hr
Start in 2026 SummerAbbVie is a leading pharmaceutical company dedicated to discovering and delivering innovative medicines. They are seeking a motivated summer intern in chemical engineering to develop process improvements for neuroscience therapies and collaborate with chemists and engineers on experimental designs and data analysis.
BiotechnologyFinancial ServicesHealth CareMedicalPharmaceuticalVenture Capital
Responsibilities
Chemical process technology experimentation, data collection and analysis of results
Collaborative experimentation between colleagues in Late-stage PDS&T and Early-stage R&D process development
Qualification
Required
Currently enrolled in university, pursuing a Bachelors in Chemical Engineering or related field
Expected graduation date between December 2026 – June 2027
Must be enrolled in university for at least one semester following the internship
Experience in chemical engineering fundamentals and lab work
Strong collaboration skills and comfort working cross-functionally
Strong writing and communication skills
Benefits
Competitive pay
Relocation support for eligible students
Select wellness benefits and paid holiday / sick time
Company
AbbVie
AbbVie is a biopharmaceutical company focused on immunology, oncology, neuroscience, virology, and aesthetics. It is a sub-organization of AbbVie.
Founded in 2013
10001+ employees
H1B Sponsorship
AbbVie has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (273)
2024 (190)
2023 (225)
2022 (284)
2021 (186)
2020 (186)
Funding
Current Stage
Public CompanyTotal Funding
$15B2024-02-27Post Ipo Debt· $15B
2023-03-08Post Ipo Equity· $0.25M
2012-12-20IPO
Leadership Team
Robert Michael
Chairman of the Board and Chief Executive Officer
Micah Bregman
Vice President, Global Strategy and Pipeline, Allergan Aesthetics
Recent News
2025-12-31
Company data provided by crunchbase